CASI Pharmaceuticals, Inc.

CASI Pharmaceuticals, Inc. financial statements

CASI Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 20.71M20-F
Net income−USD 48.06M20-F
Cash and equivalentsUSD 5.63M20-F
Total debtUSD 19.19M20-F

CASI Pharmaceuticals, Inc. financials on 6ix · CASI Pharmaceuticals, Inc. on 6ix